[Experimental decompression sickness in rabbits. Coagulation changes and therapeutic influencing].
D000818:Animals; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001772:Blood Cell Count; D001778:Blood Coagulation Disorders / Q000209:etiology*; D001779:Blood Coagulation Factors / Q000032:analysis; D001792:Blood Platelets; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D003665:Decompression Sickness / Q000150:complications*; D004620:Embolism, Fat / Q000209:etiology*; D006493:Heparin / Q000627:therapeutic use; D011817:Rabbits
D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D003509:Cyclohexanecarboxylic Acids; D006493:Heparin; D007611:Aprotinin; D001241:Aspirin
Experimentelle Dekompressionskrankheit des kaninchens. Gerinnungsveränderungen und therapeutische Beeinflussung.